regeneron pharmaceuticals
(REGN:NASDAQ GS)
As of 3:28 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
BOARD MEMBERS AFFILIATED WITH Marc Tessier-Lavigne Ph.D.*
Chief Scientific Officer and Executive Vice President of Research |  75 75 |
| ||||
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| REGN:US | $260.56 USD | -3.08 |  |
MOST CONNECTED PEOPLE TO Marc Tessier-Lavigne Ph.D.
676 RelationshipsPost a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
